Cambridge's Addenbrooke's Hospital — an internationally recognised cancer and haematology centre — manages multiple myeloma patients requiring Lenalidomide-based therapy. Lenalid 25mg provides Cambridge patients with significant cost savings following patent expiry while delivering identical therapeutic benefit.
Cambridge's research-active myeloma programme means patients here often receive cutting-edge combination regimens incorporating Lenalidomide. For international patients attending Cambridge's private oncology services, generic Lenalid provides substantial savings over branded UK pricing.
Visit medshopy.com or WhatsApp +91 82650 41513.
Cambridge's research-active myeloma programme means patients here often receive cutting-edge combination regimens incorporating Lenalidomide. For international patients attending Cambridge's private oncology services, generic Lenalid provides substantial savings over branded UK pricing.
Visit medshopy.com or WhatsApp +91 82650 41513.
